| scholarly article | Q13442814 |
| P50 | author | Paul F Pilch | Q58327163 |
| P2093 | author name string | B A Gilchrest | |
| M Yaar | |||
| P B Eisenhauer | |||
| R E Fine | |||
| S M Doyle | |||
| S Zhai | |||
| P2860 | cites work | A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain | Q24306835 |
| RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease | Q24314906 | ||
| Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation | Q24642901 | ||
| Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons | Q28584797 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction | Q70973801 | ||
| Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels | Q71034134 | ||
| Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor | Q71132186 | ||
| NGF augmentation rescues trigeminal ganglion and principalis neurons, but not brainstem or cortical whisker patterns, after infraorbital nerve injury at birth | Q72619891 | ||
| In vivo NGF treatment increases proliferation in the primary sympathetic ganglia of chick embryos | Q73028721 | ||
| The Fas death factor | Q29620461 | ||
| Induction of nerve growth factor receptors on cultured human melanocytes | Q33633203 | ||
| Nerve growth factor potentiates the neurotoxicity of beta amyloid | Q33902219 | ||
| The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. | Q34190204 | ||
| A familial Alzheimer's disease locus on chromosome 1. | Q34720942 | ||
| Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity | Q35870189 | ||
| Gene expression in cells of the central nervous system | Q36128621 | ||
| Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor | Q36233580 | ||
| Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons | Q36382469 | ||
| The molecular pathology of Alzheimer's disease | Q36490940 | ||
| Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. | Q36493889 | ||
| Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease | Q36771851 | ||
| p75 and Trk: a two-receptor system | Q40419805 | ||
| A potential role for apoptosis in neurodegeneration and Alzheimer's disease | Q40437117 | ||
| Normal and abnormal biology of the beta-amyloid precursor protein | Q40766055 | ||
| Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease | Q40801515 | ||
| Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy | Q41061364 | ||
| Amyloid beta-protein and the genetics of Alzheimer's disease | Q41074945 | ||
| NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis | Q41131864 | ||
| Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils | Q41173971 | ||
| The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide | Q41182940 | ||
| Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. | Q41208718 | ||
| Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites | Q41361443 | ||
| Hydrogen peroxide mediates amyloid beta protein toxicity | Q41460857 | ||
| High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. | Q41481526 | ||
| Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats | Q42451396 | ||
| Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon | Q42493247 | ||
| Limbic seizures increase neuronal production of messenger RNA for nerve growth factor | Q42493562 | ||
| The death domain: a module shared by proteins with diverse cellular functions. | Q42672391 | ||
| HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. | Q42811515 | ||
| Immunohistochemical evidence for apoptosis in Alzheimer's disease. | Q43561325 | ||
| Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF | Q44000637 | ||
| Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state | Q44689258 | ||
| Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons | Q45246614 | ||
| Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells | Q46054989 | ||
| Amyloid beta peptide induces necrosis rather than apoptosis | Q48123899 | ||
| Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain | Q48181791 | ||
| Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF | Q48453167 | ||
| Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). | Q48570524 | ||
| Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. | Q48887712 | ||
| Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. | Q48933977 | ||
| beta-APP cognitive function versus beta-amyloid--induced cell death. | Q52202983 | ||
| Missing Alzheimer's gene found. | Q53201156 | ||
| [Pathogenetic factors of Alzheimer disease]. | Q53312106 | ||
| Induction of cell death by endogenous nerve growth factor through its p75 receptor | Q58047180 | ||
| Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse | Q68867821 | ||
| Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding | Q69647871 | ||
| Effects of nerve growth factor on the survival of primary cultured adult and aged mouse sensory neurons | Q70757949 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 2333-2340 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease | |
| P478 | volume | 100 |
| Q28510177 | A DR6/p75(NTR) complex is responsible for β-amyloid-induced cortical neuron death |
| Q40407198 | A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging |
| Q34083364 | A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression |
| Q37293809 | Abeta aggregation and possible implications in Alzheimer's disease pathogenesis |
| Q35868063 | Adult neuron survival strategies--slamming on the brakes |
| Q35050518 | Airway neural plasticity: the nerves they are a-changin'. |
| Q34464797 | Aluminum, NO, and nerve growth factor neurotoxicity in cholinergic neurons |
| Q91781242 | Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species |
| Q34325378 | Alzheimer's disease and Abeta toxicity: from top to bottom |
| Q41677746 | Alzheimer's disease and brain development: common molecular pathways |
| Q28771710 | Alzheimer's disease brain-derived amyloid-β-mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein |
| Q35970547 | Amyloid accomplices and enforcers |
| Q24292067 | Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling |
| Q48379539 | Amyloid beta-peptide possesses a transforming growth factor-beta activity |
| Q27012950 | Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease |
| Q42033837 | Amyloid-beta binds catalase with high affinity and inhibits hydrogen peroxide breakdown |
| Q36321788 | Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway |
| Q34308827 | Apoptosis and dependence receptors: a molecular basis for cellular addiction |
| Q34068965 | Apoptosis in the nervous system |
| Q40812828 | Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes |
| Q28661691 | Apoptosis related protein-1 triggers melanoma cell death via interaction with the juxtamembrane region of p75 neurotrophin receptor |
| Q37614648 | Association of TrkA and APP Is Promoted by NGF and Reduced by Cell Death-Promoting Agents. |
| Q42466819 | Aβ selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease. |
| Q43514697 | Beta-amyloid protein (25-35) disrupts hippocampal network activity: role of Fyn-kinase. |
| Q42526585 | Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. |
| Q74130806 | Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons |
| Q39035492 | Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity |
| Q34065279 | Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease |
| Q48031063 | C-terminal peptide of γ-enolase impairs amyloid-β-induced apoptosis through p75(NTR) signaling |
| Q57891307 | Cellular Trafficking of Amyloid Precursor Protein in Amyloidogenesis Physiological and Pathological Significance |
| Q33767961 | Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo |
| Q33971339 | Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide |
| Q36803735 | Ceramide signaling in cancer and stem cells |
| Q40792753 | Characterization of a p75(NTR) apoptotic signaling pathway using a novel cellular model |
| Q27919665 | Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. |
| Q40443410 | Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. |
| Q40909041 | Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission. |
| Q41938645 | Cholinergic neurons-keeping check on amyloid β in the cerebral cortex |
| Q34459388 | Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice |
| Q35529715 | Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum |
| Q40992216 | Comparative quantitative study of 'signature' pathological lesions in the hippocampus and adjacent gyri of 12 neurodegenerative disorders |
| Q43650942 | Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides |
| Q47441289 | Complexity and Selectivity of γ-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer. |
| Q41724540 | Computational Studies of Beta Amyloid (Aβ42) with p75NTR Receptor: A Novel Therapeutic Target in Alzheimer's Disease. |
| Q93155798 | Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer's Disease |
| Q33867548 | Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease |
| Q27339637 | Differential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic marker |
| Q38252739 | Dynamic nature of the p75 neurotrophin receptor in response to injury and disease |
| Q28071845 | Effect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's Disease |
| Q35618393 | Epithelial growth control by neurotrophins: leads and lessons from the hair follicle |
| Q34461960 | Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo |
| Q64248565 | Exploring the Pathogenesis of Alzheimer Disease in Basal Forebrain Cholinergic Neurons: Converging Insights From Alternative Hypotheses |
| Q73212345 | Free radicals and lipid peroxidation do not mediate beta-amyloid-induced neuronal cell death |
| Q46463850 | Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. |
| Q46595342 | Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice. |
| Q41334124 | G-Protein-Coupled Inwardly Rectifying Potassium (GIRK) Channel Activation by the p75 Neurotrophin Receptor Is Required for Amyloid β Toxicity |
| Q33609365 | Genes and susceptible loci of Alzheimer's disease |
| Q35996424 | Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease. |
| Q38846188 | Hes1: the maestro in neurogenesis. |
| Q24628614 | Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons |
| Q36012082 | Humanin: after the discovery. |
| Q58602752 | Immune Privilege Collapse and Alopecia Development: Is Stress a Factor |
| Q33839336 | In vitro dedifferentiation of melanocytes from adult epidermis |
| Q30460471 | Increased expression of the homologue of enhancer-of-split 1 protects neurons from beta amyloid neurotoxicity and hints at an alternative role for transforming growth factor beta1 as a neuroprotector |
| Q42602562 | Inhibition of RhoA GTPase and the subsequent activation of PTP1B protects cultured hippocampal neurons against amyloid β toxicity |
| Q44167757 | Inhibition of amyloid-beta-induced cell death in human brain pericytes in vitro |
| Q77360956 | Inhibition of beta-amyloid cytotoxicity by midkine |
| Q64236162 | Innovative Therapy for Alzheimer's Disease-With Focus on Biodelivery of NGF |
| Q74045139 | Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation |
| Q40845426 | Intramuscular delivery of p75NTR ectodomain by an AAV vector attenuates cognitive deficits and Alzheimer's disease-like pathologies in APP/PS1 transgenic mice |
| Q93073768 | Knockout of p75 neurotrophin receptor attenuates the hyperphosphorylation of Tau in pR5 mouse model |
| Q40400908 | Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75. |
| Q37879671 | MAGED1: molecular insights and clinical implications |
| Q26823708 | Mechanisms of islet amyloidosis toxicity in type 2 diabetes |
| Q52096121 | Meeting report: cellular dependence--old concept, new mechanisms. |
| Q37967099 | Melanocytes: a window into the nervous system. |
| Q36135523 | Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD). |
| Q33303421 | Molecules that target beta-amyloid |
| Q57372021 | Nerve Growth Factor-induced p75-mediated Death of Cultured Hippocampal Neurons Is Age-dependent and Transduced through Ceramide Generated by Neutral Sphingomyelinase |
| Q35173879 | Nerve growth factor-dependent regulation of NADE-induced apoptosis. |
| Q35102941 | Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor |
| Q37977251 | Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain |
| Q40787888 | Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106-126). |
| Q36362330 | Neurotrophin receptor p75 mediates the uptake of the amyloid beta (Aβ) peptide, guiding it to lysosomes for degradation in basal forebrain cholinergic neurons. |
| Q22252335 | New insights into brain BDNF function in normal aging and Alzheimer disease |
| Q34544243 | Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease |
| Q38794219 | Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases. |
| Q42482479 | Overexpression of neurotrophin receptor p75 contributes to the excitotoxin-induced cholinergic neuronal death in rat basal forebrain |
| Q38608683 | Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors. |
| Q35844774 | Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. |
| Q35221871 | Pro-NGF from Alzheimer's disease and normal human brain displays distinctive abilities to induce processing and nuclear translocation of intracellular domain of p75NTR and apoptosis |
| Q35083635 | Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR. |
| Q24293094 | Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease |
| Q36942363 | RAGE is a key cellular target for Abeta-induced perturbation in Alzheimer's disease |
| Q44090700 | Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor |
| Q35009768 | Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings |
| Q91743574 | Regulation of cholinergic basal forebrain development, connectivity, and function by neurotrophin receptors |
| Q58105547 | Removal of p75 Neurotrophin Receptor Expression from Cholinergic Basal Forebrain Neurons Reduces Amyloid-β Plaque Deposition and Cognitive Impairment in Aged APP/PS1 Mice |
| Q33895321 | Resilience of precuneus neurotrophic signaling pathways despite amyloid pathology in prodromal Alzheimer's disease |
| Q41030973 | Resistance to the apoptotic effect of aggregated amyloid-beta peptide in several different cell types including neuronal- and hepatoma-derived cell lines |
| Q48304478 | Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Abeta-induced cytotoxicity |
| Q33940352 | Role of macrophage activation in the pathogenesis of Alzheimer's disease and human immunodeficiency virus type 1-associated dementia |
| Q41792400 | Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines |
| Q28574751 | Selective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interaction |
| Q40746413 | Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection |
| Q98280974 | Signaling via the p75 neurotrophin receptor facilitates amyloid-β-induced dendritic spine pathology |
| Q39982408 | Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity |
| Q34366768 | Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease |
| Q33797754 | Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice |
| Q28077671 | Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students |
| Q50138252 | Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5. |
| Q91760283 | Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance |
| Q38589876 | TRAF6 and p62 inhibit amyloid β-induced neuronal death through p75 neurotrophin receptor |
| Q35749321 | Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells |
| Q34203015 | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). |
| Q38281324 | The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease |
| Q33197281 | The Gtx homeodomain transcription factor exerts neuroprotection using its homeodomain |
| Q35542857 | The Interface between Cytoskeletal Aberrations and Mitochondrial Dysfunction in Alzheimer's Disease and Related Disorders |
| Q74257453 | The amyloid peptide induces early genotoxic damage in human preneuron NT2 |
| Q27687404 | The dendritic hypothesis for Alzheimer's disease pathophysiology |
| Q33799169 | The evolution of aging-related brain change |
| Q37845036 | The many substrates of presenilin/γ-secretase |
| Q33264215 | The modular systems biology approach to investigate the control of apoptosis in Alzheimer's disease neurodegeneration |
| Q34387881 | The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses |
| Q34982367 | The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system |
| Q35809284 | The p75 neurotrophin receptor can induce autophagy and death of cerebellar Purkinje neurons. |
| Q42459051 | The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo |
| Q33953244 | The p75 receptor: first insights into the transduction mechanisms leading to either cell death or survival. |
| Q39439973 | The p75NTR extracellular domain: a potential molecule regulating the solubility and removal of amyloid-β. |
| Q37490683 | The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease |
| Q43652147 | Zinc inhibits p75NTR-mediated apoptosis in chick neural retina |
| Q39192100 | p75 Neurotrophin Receptor in the Skin: Beyond Its Neurotrophic Function |
| Q47860140 | p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis. |
| Q39620971 | p75 neurotrophin receptor mediates apoptosis in transit-amplifying cells and its overexpression restores cell death in psoriatic keratinocytes. |
| Q44548784 | p75 neurotrophin receptor protects primary cultures of human neurons against extracellular amyloid beta peptide cytotoxicity. |
| Q35927582 | p75 neurotrophin receptor signaling in the nervous system. |
| Q37194848 | p75 reduces beta-amyloid-induced sympathetic innervation deficits in an Alzheimer's disease mouse model |
| Q33908462 | p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation |
| Q36594558 | p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease |
| Q57892018 | p75NTR is mainly responsible for Aβ toxicity but not for its internalization: a primary study |
| Q42483752 | p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain. |
| Q34212626 | α7 Nicotinic receptor activation reduces β-amyloid-induced apoptosis by inhibiting caspase-independent death through phosphatidylinositol 3-kinase signaling |
Search more.